معرفی
Marc Cox is a Professor in the Department of Pharmaceutical Sciences at the University of Texas at El Paso (UTEP), with additional affiliations in Biological Sciences and the Border Biomedical Research Center (BBRC). As a molecular endocrinologist, his research focuses on steroid hormone receptor signaling pathways regulated by chaperone proteins, particularly FKBP51 and FKBP52 immunophilins.
- Develops selective FKBP inhibitors for hormone-related diseases
- Expert in yeast genetics and high-throughput drug screening
- Investigates molecular mechanisms of receptor folding and hormone binding
His recent work explores FKBP52 targeting in prostate and breast cancer therapies, revealing novel insights into Hsp90-cochaperone interactions. Collaborations with TTUHSC El Paso and national institutions have expanded impact in cancer detection and biomedical training programs.
- Lead investigator on multiple NIH-funded projects
- Speaker at international symposia on stress responses
- Recipient of National Academy of Inventors recognition
While his publications span from 2002–2025, key trends focus on cancer signaling, stress response proteins, and translational drug development. Current efforts include creating chemical tools for Hsp70 interactome studies and optimizing anti-cancer molecules like MJC13.
